- Ms. Murino’s work in assuring antitrust clearance in publicly announced transactions which were required to be reported under the HSR Act include:
- Onyx Pharmaceuticals in its $10.4 billion acquisition by Amgen
- ProBuild Holdings in its $1.6 billion acquisition by Builders FirstSource
- Lynda.com, Inc. in its $1.5 billion acquisition by LinkedIn Corporation
- Partners Group in its $1.5 billion acquisition of Knowledge Universe Education
- Xoom Corporation in its $890 million acquisition by eBay
- Reliant Hospital Partners in its $730 million acquisition by HealthSouth Corporation
- AMAG Pharmaceuticals in its $700 million acquisition of Cord Blood Registry
- Investor AB and Patricia Industries in their $415 million acquisition of BraunAbility
- Ocata Therapeutics in its sale to Astellas Pharma for approximately $380 million
- Guerbet Pharmaceuticals in its $270 million acquisition of Mallinckrodt’s Contrast Medial Delivery Systems Business
- Millennial Media, Inc. in its approximately $250 million sale to Verizon Communications, Inc. and AOL, Inc.
- Primus Capital in a $180 million sale of its portfolio company AOD Software to MatrixCare
Other notable work for clients outside the HSR context includes:
- Representing Beth Israel Deaconess Medical Center, Atrius Health, Lahey Health, and Tufts University Medical Center in successfully blocking a nonprofit health organization's acquisition of South Shore Hospital Corporation and Hallmark Health. This was the first time a state court rejected a proposed antitrust settlement between the Massachusetts Attorney General's Office and private entities.
- Providing antitrust counsel and guidance to multiple healthcare providers and healthcare systems across the United States seeking to expand their networks in proceedings before the federal antitrust authorities, their relevant state regulatory bodies, and state attorneys general.
- Successfully representing multiple third parties in the federal district court proceedings related to the FTC and DOJ merger challenges
- Providing ongoing, confidential guidance to three leading international investment advisors regarding risks of antitrust enforcement and potential remedies in connection with multi-billion dollar transactions.
Ms. Murino is a member of the District of Columbia Bar Association, the American Bar Association (ABA), and the American Health Lawyers Association (AHLA). She is active in the ABA’s Section of Antitrust Law, presently serving as chair of the Programs and Teleseminars Committee, where she helps oversee the planning of 8-9 conferences per year related to various antitrust topics. She previously served as vice chair of the 2014 Clayton Act at 100 Symposium, the 2013 Fall Forum, the 2013 Merger Retrospective Symposium, and the 2012 Presidential Transition Report Task Force. As a member of the AHLA, she frequently leads webinars to educate lawyers on developments at the intersection of healthcare and antitrust law.
Ms. Murino routinely guest lectures on antitrust topics at American University's Washington College of Law, Boston University School of Law, the Columbus School of Law at Catholic University, George Washington University Law School, and the University of Michigan Law School. For eight years, she served as an adjunct professor of legal research and writing at George Washington University Law School. Ms. Murino is also president of the American University Alumni Association, her undergraduate alma mater, where she represents the institution’s more than 120,000 alumni.